Table III.
A, Univariate analysis | |||
---|---|---|---|
Variables | HR | 95% CI | P-value |
EZH2 expression | 2.872 | 1.204–6.349 | 0.009 |
Age | 2.142 | 0.936–4.898 | 0.071 |
Sex | 1.983 | 0.851–4.619 | 0.113 |
Tumor size | 2.290 | 1.019–5.148 | 0.045 |
Lymph node metastases | 2.297 | 1.022–5.164 | 0.044 |
Histological differentiation | 2.448 | 1.107–5.414 | 0.027 |
Tumor stage | 2.717 | 1.209–6.108 | 0.016 |
B, Multivariate analysis | |||
Variables | HR | 95% CI | P-value |
EZH2 expression | 2.625 | 1.204–5.722 | 0.015 |
Age | – | – | – |
Sex | – | – | – |
Tumor size | 2.499 | 1.128–5.537 | 0.024 |
Lymph node metastases | 2.485 | 1.122–5.505 | 0.025 |
Histological differentiation | 2.551 | 1.168–5.573 | 0.019 |
Tumor stage | 2.737 | 1.270–5.900 | 0.010 |
HR, hazard ratio, CI, confidence interval; EZH2, enhancer of zeste homolog 2.